BIOA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Canada Goose GOOS Q1 2026 Earnings EPS Miss Amidst Quiet Market Response BBAI Q1 2026 Earnings EPS Misses Estimates as Company Navigates AI Market Headwinds Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress CRMD Q1 2026 Earnings Strong EPS Beat Driven by Milestone Payments OII Q1 2026 Earnings EPS Beats Estimates by 116 Stock Edges Higher